EXCLUSIVE ONLINE CONTENT
Parexel, a leading provider of solutions to accelerate the development and delivery of innovative new therapies to improve world health recently announced…..
A Purdue team has received a $3.2-million grant from the National Institutes of Health for its work to treat antibiotic-resistant lower respiratory infections – the fourth-leading cause of…
Saama Technologies, Inc. recently announced it signed an agreement with Pfizer Inc. to develop and deploy an AI-powered analytics solution to reduce the….
TriSalus Life Sciences & Roger Williams Medical Center Announce Initiation of Phase 1 Clinical Trial for a Novel Delivery Technology
TriSalus Life Sciences recently announced the initiation of a new clinical trial assessing the safety and feasibility of an innovative new treatment that combines its…..
Alkahest, Inc. recently announced the initiation of a Phase 2b clinical trial of its orally administered small molecule CCR3 inhibitor, AKST4290. The company has dosed the first….